FDA Grants Approval for Valsartan ANDA218897 by Laurus
The FDA has granted an Abbreviated New Drug Application (ANDA) approval for Valsartan submitted by Laurus.
Asset / Drug
Drug and asset intelligence for Laurus with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.